https://www.selleckchem.com/pr....oducts/Everolimus(RA
We compared the schedule's capability of enabling timely intervention before the occurrence of the PE and number of measurements needed. As compared to a pre-defined trimonthly scheduling approach, personalized scheduling of glomerular and tubular biomarker measurements showed similar performance with regard to prognostication, but required a median of 0.4-2.7 fewer measurements per year. Personalized scheduling is expected to reduce the number of patient visits and healthcare costs. Thus, it may contribute to efficient monit
Like
Comment
Share
